Both homozygous CDKN2A and CDKN2B deletions and heterozygous PAX5 deletions are frequent abnormalities in pediatric and adult B-ALL [15, 28, 29], and are valuable markers for disease monitoring. This evidence concerns the gene CDKN2B and precursor B-cell acute lymphoblastic leukemia.